Platte River Capital’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
$967K Sell
58,906
-63,311
-52% -$1.08M 0.89% 40
2015
Q2
$2.16M Sell
122,217
-11,093
-8% -$198K 1.09% 29
2015
Q1
$2.37M Hold
133,310
1.06% 30
2014
Q4
$1.77M Sell
133,310
-44,200
-25% -$565K 0.66% 55
2014
Q3
$2.1M Sell
177,510
-135,570
-43% -$1.71M 0.54% 64
2014
Q2
$4M Sell
313,080
-10,280
-3% -$134K 0.61% 63
2014
Q1
$4.37M Sell
323,360
-61,570
-16% -$808K 0.59% 67
2013
Q4
$4.63M Sell
384,930
-56,740
-13% -$670K 0.59% 59
2013
Q3
$5.18M Sell
441,670
-55,830
-11% -$604K 0.64% 57
2013
Q2
$4.61M Buy
+497,500
New +$4.22M 0.54% 70

Other funds holding BSX

Platte River Capital's BSX Position: Q3 2015 in Review

Platte River Capital reduced its Boston Scientific (BSX) stake by 52% in Q3 2015, selling an estimated $1.08M and leaving 58,906 shares worth $967K. The position accounts for 0.89% of the portfolio, ranked #40.

Platte River Capital first reported a position in BSX in Q2 2013 and has held it in 10 quarters since. The position peaked at $5.18M in Q3 2013. 480 funds tracked by Wall St. Rank hold BSX as of Q3 2015.

  • Platte River Capital held 58,906 shares of Boston Scientific worth $967K as of Q3 2015.
  • Platte River Capital sold 63,311 Boston Scientific shares in Q3 2015, an estimated $1.08M.
  • Boston Scientific made up 0.89% of Platte River Capital's portfolio in Q3 2015, its #40 holding.
  • Platte River Capital first reported a position in Boston Scientific in Q2 2013 and has held it in 10 quarters since.
  • Platte River Capital's Boston Scientific position peaked at $5.18M in Q3 2013.
  • 480 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2015.

Based on Platte River Capital's 13F filing for Q3 2015, filed 12 Nov 2015.